Current Cancer Drug Targets
Volume 22, 11 Issues, 2022
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Contents
Current Cancer Drug Targets , Volume 7 - Number 7
Pathobiology of Head and Neck Squamous Tumorigenesis
, 7(7): 606 - 612Adel K. El-Naggar
DOI: 10.2174/156800907782418338
Current Status and Future Perspectives of Chemoprevention in Head and Neck Cancer
, 7(7): 623 - 632Carmen M. Klass and Dong M. Shin
DOI: 10.2174/156800907782418347
Anti-Tumor Vaccines in Head and Neck Cancer: Targeting Immune Responses to the Tumor
, 7(7): 633 - 642Theresa L. Whiteside
DOI: 10.2174/156800907782418310
Targeting Angiogenesis in Head and Neck Cancer
, 7(7): 643 - 649Nabil F. Saba, Dong M. Shin and Fadlo R. Khuri
DOI: 10.2174/156800907782418356
EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
, 7(7): 650 - 665Igor Astsaturov, Roger B. Cohen and Paul Harari
DOI: 10.2174/156800907782418365
Recent Advances in Combined Modality Therapy for Locally Advanced Head and Neck Cancer
, 7(7): 674 - 680Lori J. Wirth and Marshall R. Posner
DOI: 10.2174/156800907782418329
Recent Approaches in Chemoprevention of Prostate Cancer
, 7(7): 681 - 688Charles Y.F. Young
DOI: 10.2174/156800907782418284
Targeting MDM2 and MDMX in Retinoblastoma
, 7(7): 689 - 695Nikia A. Laurie, Chie Schin-Shih and Michael A. Dyer
DOI: 10.2174/156800907782418266
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net